Showing results (831-840 of 999) with videos related to
Sort By:
Pageof 100
Clinical Cardiology|March 7, 2016
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) TrialSteven E Nissen, Ricardo E Dent-Acosta, Robert S Rosenson, et al.The New England Journal of Medicine|April 1, 2014
A 52-week placebo-controlled trial of evolocumab in hyperlipidemiaDirk J Blom, Tomas Hala, Michael Bolognese, et al.Journal of Lipid Research|February 23, 2025
Foamy monocytes and atherogenesis in mice with combined hyperlipidemia and effects of antisense knockdown of apoCIIIXueying Peng, Zeqin Lian, Veronica O'Brien, et al.JACC. Basic to Translational Science|June 16, 2023
Dietary Effects on Monocyte Phenotypes in Subjects With Hypertriglyceridemia and Metabolic SyndromeZeqin Lian, Xiao-Yuan Dai Perrard, Antu Kalathookunnel Antony, et al.Circulation|May 18, 2026
Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT TrialJ Dawn Abbott, Jocelyne R Benatar, Colleen M Ballantyne, et al.Circulation|January 15, 2020
Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort StudyAlana A Lewis, Colby R Ayers, Elizabeth Selvin, et al.Atherosclerosis|April 28, 2015
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trialHamed Emami, Esad Vucic, Sharath Subramanian, et al.Atherosclerosis|July 14, 2012
A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, StudiesAriel Brautbar, Lisa A Pompeii, Abbas Dehghan, et al.Research Square|January 23, 2024
N-acetylaspartate from fat cells regulates postprandial body temperatureJessica B Felix, Pradip K Saha, Evelyn de Groot, et al.Methodist Debakey Cardiovascular Journal|August 15, 2012
Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-careNicolaos Christodoulides, Floriano N Pierre, Ximena Sanchez, et al.Pageof 100